Alkermes (ALKS)
(Real Time Quote from BATS)
$24.19 USD
+0.19 (0.79%)
Updated May 24, 2024 12:48 PM ET
3-Hold of 5 3
A Value B Growth C Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
ALKS 24.19 +0.19(0.79%)
Will ALKS be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for ALKS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ALKS
Do Options Traders Know Something About Alkermes (ALKS) Stock We Don't?
Alkermes' (ALKS) Q1 Earnings & Revenues Fall Shy of Estimates
ALKS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Alkermes (ALKS) Reports Q1 Earnings: What Key Metrics Have to Say
Alkermes (ALKS) Q1 Earnings and Revenues Miss Estimates
Deciphera Pharmaceuticals, Inc. (DCPH) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Other News for ALKS
6 Analysts Assess Alkermes: What You Need To Know
Alkermes price target raised by $5 at Cantor Fitzgerald, here's why
Alkermes price target raised by $5 at Cantor Fitzgerald, here's why
ALKS July 19th Options Begin Trading
The Bottom Fishing Club: Alkermes Has Great Value And Safety